Five-year Safety Data from 5 Clinical Trials of Subcutaneous Golimumab in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis.
- Resource Type
- journal article
- Source
- Journal of Rheumatology; Dec2016, Vol. 43 Issue 12, p2120-2130, 11p
- Subject
- Language
- ISSN
- 0315162X